Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Freezing Temperatures Became the Hottest Trend in Wellness

The beauty industry is an economic gold mine and consumers are on a constant journey of exploration. One practice in particular, cryotherapy, has continued to defy conventional wisdom within the anti-aging and weight loss industry. The emerging method has both women and men pouring money into this cutting-edge wellness movement. What began as a pain…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The beauty industry is an economic gold mine and consumers are on a constant journey of exploration. One practice in particular, cryotherapy, has continued to defy conventional wisdom within the anti-aging and weight loss industry. The emerging method has both women and men pouring money into this cutting-edge wellness movement.

What began as a pain management tool and treatment for cancers, dementia and other illnesses, has transformed into an increasingly popular health craze.

The Science Behind the Craze

Cryotherapy is the process of subjecting the body to temperatures of up to -200 degrees Fahrenheit for around three minutes in a localized chamber. Physiologically, the change in temperature triggers a fight or flight response, forcing the body to enrich the organs with oxygen and increase circulation in an attempt to survive.

In 2015, the global cryotherapy market accounted for $2.5 billion and is projected to grow at a compound annual growth rate of 9.7% during a forecast period that continues to 2024, according to Grandview Research.

The cosmetic results of the process have been known to reduce cellulite, kick-start the metabolism, increase collagen production that reduces wrinkles and tighten pores. It has even been shown to release endorphins due to a Zen-like feeling that comes when the brain is forced into a heightened state, desperate for subsistence.

The extremes we go to for beauty, right?

Warming up to Change

While a lot of industries are hesitant to introduce change and risk breaking consumer routines, beauty and wellness is not one of them.

President and CEO of Shiseido Americas Marc Rey highlighted in an interview with Forbes that traditional makeup sales were down 1.3% in 2016, but independent brands were up 42.7%. This industry is a rare one in the sense that consumers are not only open to change, but often want to be the first to embrace it. Trends that begin as “hole in the wall” businesses like cryotherapy attract a fresh demographic and the growth of these types of corporations represent just how receptive consumers are to change.

While the more superficial benefits have yielded an incredible market, the medical-centric consumers back research adequate to warrant transforming oneself into a human icicle.

The chamber freezes abnormal tissue which can be attributed to killing certain cancers. The freezing conditions act as an ice bath taken to an extreme which helps aches, pains, muscle recovery and arthritis. Other medical benefits include migraine treatment, and the anti-inflammatory and oxidative stress process has even been known to help treat Alzheimer’s disease and Dementia.

Is the Freeze a Fad?

From a business standpoint, consumer behavior in response to a trend is not necessarily a telling factor of how the future of an industry will perform. However, consider this statement: no pain, no gain. We as consumers have translated this saying into our health, beauty and overall attitude about wellness. As technology and science continue to manifest new ways to achieve beauty, consumers have raised expectations on results.

In other words, if we were suddenly expected to fetch our water from a river and manually purify it, filling the Brita would not seem so arduous. Consumers are more and more willing to try new trends as the number of opportunities or services themselves increase.

While certain fads are important in how businesses adapt, they are not dependent on dynamic consumer behavior but rather on this overarching theme that combines millennials’ expectations with subjection to science experiments of their own volition. Cryotherapy is no exception.

Participating in trends allows consumers to feel like they are fully utilizing this science and technology. While Cryo might seem drastic compared to conventional methods of weight loss or anti-aging, this is the reality in how the beauty industry has evolved, and corporations have every right to capitalize on it in hopes of remaining relevant in a rapidly changing market.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512